Integrins in Drug Targeting-RGD Templates in Toxins

Author(s): X. Lu, D. Lu, M. F. Scully, V. V. Kakkar

Journal Name: Current Pharmaceutical Design

Volume 12 , Issue 22 , 2006

Become EABM
Become Reviewer
Call for Editor


Integrins are a family of heterodimeric receptors, which modulate many cellular processes including: growth, death (apoptosis), adhesion, migration, and invasion by activating several signaling pathways. Integrin-binding RGD (arginine- glycine-aspartic acid) is found in several important extracellular matrix proteins which serve as adhesive integrin ligands. The RGD motif has also been found in many toxins from snake venom and other sources that specifically inhibit integrin binding function and serve as potent integrin antagonists, particularly of platelet aggregation and integrinmediated cell adhesion. Many of these proteins have potential as therapeutic agents which can target integrins directly. Structural and functional studies of several RGD-containing toxins suggest that the inhibitory potency of these proteins lies in subtle positional requirements of the tripeptide RGD at the tip of a flexible loop, a structural feature for binding to integrins. In addition, amino acid residues in this loop in close vicinity to the RGD-motif determine the integrin-binding specificity and selectivity. This review will present a review of integrin structure and function, and of disintegrin structural features responsible for their activity as antagonists of integrin function. The use of integrins in drug targeting and integrins as targets for drug delivery by using the RGD as a template structure will also be discussed

Keywords: ADAM proteins, antagonist, cell adhesion, disintegrin, integrin, platelet aggregation, RGD-motif, venom toxins

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [2749 - 2769]
Pages: 21
DOI: 10.2174/138161206777947713
Price: $65

Article Metrics

PDF: 15